Volkswagen to close all European plants for COVID-19

▴ Volkswagen to close all European plants for COVID19
German automaker Volkswagen says it is shutting down most of its European plants for two weeks due to the virus outbreak.

Volkswagen said Tuesday it would close a large portion of its European plants for about fourteen days because of vulnerability about interest for vehicles and supplies of parts in the midst of the infection flare-up.

Chief Herbert Diess made the declaration toward the beginning of the organization's yearly news meeting. The DPA news office, referring to worker delegates, said that the last moves would run this Friday in many areas.

The organization had said it expects a 4% expansion in deals this year yet Chief Financial Officer Frank Witter said Tuesday that vulnerability about the seriousness and term of the infection flare-up made it difficult to give a dependable expectation. Diess said 2020 would be "a troublesome year" as the infection flare-up "presents us with obscure difficulties."

Volkswagen a year ago caused a net benefit of 14.02 billion euros, to up 15% from 12.2 billion euros in 2018. Income for the year rose 7% to 252.6 billion euros ($281 billion).

Copyright 2020 The Associated Press. All rights saved. This material may not be distributed, communicated, reworked or redistributed.

Tags : #Volkswagen #Germany #Frankfurt #Closeallplants #COVID #EU #Dasauto

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Sanjeevani Healthcare & Wellness Expo 2024: A Dynamic Platform for Global Healthcare CollaborationDecember 23, 2024
Ranitidine: Saviour or Suspect? The Truth Behind the Stomach Acid RemedyDecember 23, 2024
From One-Size-Fits-All to Precision Medicine: The New Hope for Rare Bone Cancer PatientsDecember 23, 2024
World Meditation Day: India’s Gift of Peace to a Chaotic WorldDecember 23, 2024
Breaking New Ground in Migraine Care: A Landmark Session on Diagnosis and TreatmentDecember 23, 2024
Black Angels remind us of centuries of injustices plaguing the TB responseDecember 20, 2024
Healthcare Startups to Watch Out for in 2025December 20, 2024
Biobank Blueprint: Redefining Diabetes Diagnosis and Treatment in IndiaDecember 20, 2024
The Future of Malaria Prevention: Can This Vaccine Eliminate the Disease?December 20, 2024
Why the World Trusts Indian Pharmaceuticals for Life-Saving SolutionsDecember 20, 2024
International Tsunami Conference Concludes at AmritapuriDecember 20, 2024
Prestige Marks 75 Years of Revolutionizing Home Cooking with Iconic Innovative ProductsDecember 20, 2024
Revolutionizing Education: Online Learning Platforms Transforming Study Materials for Board and Competitive ExamsDecember 19, 2024
Why Your Blood Pressure Reading Might Be a Lie and How to Fix ItDecember 19, 2024
Vaccines, Cards, and Digital Records: How India is Fighting Healthcare InequalityDecember 19, 2024
Bridging Borders: Sri Lanka’s President Explores India’s Healthcare and HeritageDecember 19, 2024
Jeevan Jyoti Project Brings Eye Care to Alwar's Rural CommunitiesDecember 19, 2024
Crompton Launches New Range of Decorative Wall Lights Providing a Perfect Blend of Uniqueness & AestheticsDecember 19, 2024
Can One Injection End Decades of HIV Inequality?December 19, 2024
Multi-Organ Marvel: How a 12-Hour Surgery Gave a Businessman New LifeDecember 19, 2024